Enzolytics Inc (ENZC)

[OTCShotCaller]

Well said!There's no other Biotech Company in history sitting on what BioClonetics-Enzolytics has! There's simply nothing that compares to it!

Post-Merger, they have the potential of rapidly becoming the largest Market Cap Biotech traded on the Stock Exchange, keeping in mind that many of them commonly trade at 40-to-80X earnings!

The way I see it playing out is as follows IMO:

1). Post-Merger combined with coming current on ALL filings, and BioClonetics 135M valuation factored in: PPS easily $0.50-to-1.00

2). Funding from various sources: $1.25-to-1.50

3). Primate Studies under way at UC Davis: $1.55-to-$1.75

4). Confirmation of the Clone3's efficacy on Primates (in-Vivo) as it was in-Vitro: $2.50-to-$3.75

5). Transitioning to Clinical Trials Phase I-IV: $3.85-$5.25

6). Validated preliminary results from Clinical Trials: $5.50 to $15.00

7). FDA Application for commercialization and distribution: $15-$50

8). Big Pharma partner named for manufacturing, marketing, and global distribution. $55-to-$85

9). Transition to NASDAQ with Institutional Interest/Stock Purchasing: $95 -to-$125

10). Earning beginning to fall to bottom line: $150-$225

11). Post Big Pharma Buy Out: $300+

Again, just my opinion. Many other factors will obviously come into play as well I didn't mention, i.e. the commercialization of Enzolytics ITV-1 in the U.S. that will likely occur within 6 months of the Merger.